Narrow search
Showing 1 - 10 of 28,387
Cover Image
Variations in external reference pricing implementation : does it matter for public policy?
Gill, Jennifer; Fontrier, Anna-Maria; Kyriopoulos, Dionysis - In: The European journal of health economics : HEPAC ; … 20 (2019) 9, pp. 1375-1397
Persistent link: https://www.econbiz.de/10012221376
Cover Image
The effects of price regulation on pharmaceutical expenditure and availability
Kortelainen, Mika; Markkanen, Jaakko; Siikanen, Markku; … - 2023
Persistent link: https://www.econbiz.de/10014431650
Cover Image
An empirical model of drug pricing and competition : a dynamic perspective
Camejo, Rodrigo Refoios; McGrath, Clare; Rutten, F. F. H. - In: International journal of economics and business research 6 (2013) 2, pp. 173-193
Persistent link: https://www.econbiz.de/10010351165
Cover Image
Using health technology assessment to assess the value of new medicines : results of a systematic review and expert consultation across eight European countries
Angelis, Aris; Lange, Ansgar; Kanavos, Panos - In: The European journal of health economics : HEPAC ; … 19 (2018) 1, pp. 123-152
Persistent link: https://www.econbiz.de/10011946167
Cover Image
Pricing the pharmaceuticals when the ability to pay differs
Kanniainen, Vesa; Laine, Juha; Linnosmaa, Ismo - In: Journal of the Finnish Economic Association : JFEA 2 (2021) 1, pp. 25-48
A non-trivial fraction of people cannot afford to buy pharmaceutical products at unregulated market prices. This paper analyses the public insurance of a patent-protected pharmaceutical product in terms of price controls and socially optimal third-degree price discrimination. First, the paper...
Persistent link: https://www.econbiz.de/10013286496
Cover Image
Impact of price control on pharmaceutical sector with reference to India
Kolte, Ashutosh; Mal, Hoshiar; Fulambrikar, Mugdha; … - In: International journal of intelligent enterprise 8 (2021) 1, pp. 90-104
Persistent link: https://www.econbiz.de/10012512495
Cover Image
Effects of pharmaceutical price regulation : China's evidence between 1997 and 2008
Wu, Binzhen; Zhang, Qiong; Qiao, Xue - In: Journal of the Asia Pacific economy 20 (2015) 2, pp. 290-329
Persistent link: https://www.econbiz.de/10011378658
Cover Image
Late-stage pharmaceutical R&D and pricing policies under two-stage regulation
Jobjörnsson, Sebastian; Forster, Martin; Pertile, Paolo; … - In: Journal of health economics 50 (2016), pp. 298-311
Persistent link: https://www.econbiz.de/10011589153
Cover Image
Fair prices for medicines? : exploring competent authorities’ and public payers’ preferences on pharmaceutical policies
Vogler, Sabine - In: Empirica : journal of european economics 46 (2019) 3, pp. 443-469
Persistent link: https://www.econbiz.de/10012242289
Cover Image
Pharmaceutical regulation and health policy objectives
Birg, Laura - 2013
public expenditure, limiting financial exposure of patients, improving access to pharmaceuticals, and stimulating competition …
Persistent link: https://www.econbiz.de/10010224844